Behcets Disease Market Size

  • Report ID: 5795
  • Published Date: Mar 04, 2024
  • Report Format: PDF, PPT

Behcets Disease Market Size

Behcet's Disease Market size is estimated to reach USD 685 Million by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of behcet’s disease was USD 270 Million. The increase in Behcet’s disease cases globally is fueling the expansion of the market. For instance, according to a report published in 2022 states, the frequency of Behcet’s Disease in Japan, Korea, China, Iran, and Saudi Arabia ranges from 13.5 to 22 cases per 100,000 population. The prevalence in North America and Europe is 1 case per 15,000-500,000 population. The widespread of the disease globally is increasing due to rapid recognition of the disease and immigration from endemic areas. Fast recognition of the disease leads to a higher demand for available treatment & field research.

Major shifts are taking place in environmental factors related to genetics refers to exposure to toxic substances and acceptance of an unhealthy lifestyle that can increase an individual’s risk of disease are anticipated to boost the expansion of the market. Additionally, increased awareness of the disease in the healthcare sector disease can help with more precise diagnosis and treatment.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5795
  • Published Date: Mar 04, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increase in incidences of Behcet’s disease & technological advancements in healthcare sector are major factors driving the growth of the behcet's disease market.

The market size of behcet's disease market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024 - 2036.

The major players in the market are Pfizer Inc., Gyroscopic Therapeutics, Novartis AG, AbbVie, F. Hoffmann La Roche Ltd., Johnson and Johnson, Panacea Biotec, Gentech and others.

The corticosteroid segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample